the future of car-t for hematological malignancies and solid tumors
Published 7 months ago • 99 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
2:11
pirtobrutinib as a bridge to car-t therapy in b-cell malignancies
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
2:10
mechanisms of resistance to car t-cells in myeloma & future considerations
-
3:43
the future of car-t therapy
-
2:30
the future of car t-cell therapy
-
0:54
future of car-t
-
3:06
the promise of car-t therapy in adult all and future outlooks
-
1:01:36
deciphering car-t cells: exploring functional mechanisms to drive next generation immunotherapy
-
1:00:30
what’s next in car t cell therapy with dr. michel sadelain
-
41:39
2022 wmif | the cell therapy landscape | car-t to stem cells
-
3:07
the role of bridging and timing in car-t
-
4:34
future perspectives in car-t therapy
-
2:56
the future landscape of car t-cell therapy
-
2:39
the future of car-t therapy: earlier use, new indications, & improved manufacturing
-
0:52
the future of car t-cell therapy for aml
-
4:02
the future of car-t and cellular therapy
-
1:20
exciting research in the car-t space: the promise of allogeneic therapies
-
2:27
the future of car-t cell therapy in europe
-
2:53
safety and efficacy of allogenic car-t cell treatment
-
1:04
the major hurdles and emerging opportunities of car t-cell therapy
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma